000			02155 a2200625 4500
005			20250514001441.0
264		0	_c20010809
008			200108s 0 0 eng d
022			_a0085-2538
024	7		_a10.1046/j.1523-1755.2001.00737.x _2doi
040			_aNLM _beng _cNLM
100	1		_aRodríguez-Iturbe, B
245	0	0	_aMycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure. _h[electronic resource]
260			_bKidney international _cJun 2001
300			_a2222-32 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAngiotensin II _xanalysis
650	0	4	_aAnimals
650	0	4	_aAnti-Inflammatory Agents, Non-Steroidal _xpharmacology
650	0	4	_aBlood Pressure _xdrug effects
650	0	4	_aBody Weight
650	0	4	_aCell Division _xphysiology
650	0	4	_aCreatinine _xblood
650	0	4	_aDisease Models, Animal
650	0	4	_aFibronectins _xanalysis
650	0	4	_aHypertension, Renal _xchemically induced
650	0	4	_aKidney _xchemistry
650	0	4	_aLeukocytes, Mononuclear _ximmunology
650	0	4	_aLipid Peroxidation _xdrug effects
650	0	4	_aMale
650	0	4	_aMalondialdehyde _xurine
650	0	4	_aMycophenolic Acid _xanalogs & derivatives
650	0	4	_aOsteopontin
650	0	4	_aRats
650	0	4	_aRats, Sprague-Dawley
650	0	4	_aReceptor, Angiotensin, Type 1
650	0	4	_aReceptor, Angiotensin, Type 2
650	0	4	_aReceptors, Angiotensin _xanalysis
650	0	4	_aSialoglycoproteins _xanalysis
650	0	4	_aSuperoxides _xmetabolism
650	0	4	_aVasoconstrictor Agents _xanalysis
700	1		_aPons, H
700	1		_aQuiroz, Y
700	1		_aGordon, K
700	1		_aRincón, J
700	1		_aChávez, M
700	1		_aParra, G
700	1		_aHerrera-Acosta, J
700	1		_aGómez-Garre, D
700	1		_aLargo, R
700	1		_aEgido, J
700	1		_aJohnson, R J
773	0		_tKidney international _gvol. 59 _gno. 6 _gp. 2222-32
856	4	0	_uhttps://doi.org/10.1046/j.1523-1755.2001.00737.x _zAvailable from publisher's website
999			_c11312094 _d11312094